RxDoctor Payments Data

Saroj Neupane, MD

Internal Medicine · Detroit, MINPI 1801184296

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $264,817 of the $373,099 with a category attached, or 71.0%. 25 manufacturers reported payments, led by Boston Scientific at 50.1% of the total. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$373,099in general payments, 2019–2025

Across 587 payments — averaging $635.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$187K
  • Cardiovascular Systems Inc.$72K
  • Shockwave Medical, Inc$35K
  • Teleflex LLC$28K
  • Abiomed$20K
  • Abbott$12K
  • plus $19K from 19 others
$113,621in research payments, 2019–2025

Across 30 payments — averaging $3787.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cardiovascular Systems Inc.$41K
  • Boston Scientific$35K
  • Shockwave Medical, Inc$21K
  • Abbott$17K

What the payments were for

  • Consulting fees$18,5005%
  • Speaking & faculty fees$264,81771%
  • Grants$37,63510%
  • Travel & lodging$20,0265%
  • Food & beverage$32,1229%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$373,099 in reported general payments places this provider in the 95th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$109,536
Medicare patients
176
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab74$45,571
EliquisApixaban60$43,135
BrilintaTicagrelor27$13,610
Repatha SyringeEvolocumab14$10,832
ClopidogrelClopidogrel Bisulfate163$1,774
Ranolazine ErRanolazine15$1,707
Rosuvastatin Calcium61$1,032
Metoprolol Succinate82$822
Amlodipine Besylate77$426
Atorvastatin Calcium48$353
Losartan Potassium36$325
Lisinopril30$296
Carvedilol36$228
Pravastatin Sodium11$130
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$127

Paid to pharmacies, not to this prescriber.

Other internal medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →